Winter 2022 could be brutal. In fact, NOAA's Climate Prediction Center said the December-February temperature outlook depicts elevated odds of below-normal temperatures over the northern U.S., stretching from the Pacific Northwest to parts of the western Great Lakes. It's also…
One of the best year-end strategies to consider is the Dogs of the Dow. At the start of the year, you simply buy the top 10 highest-yielding stocks on the most beaten-down stocks on the Dow Jones. In 2021, the…
One of the best ways to spot potential opportunities is by tracking insiders. After all, who knows the company better than an insider – the CEO, CFO, COO, officers, employees, and directors? If they’re buying a sizable number of shares,…
Goldman Sachs just took down lithium stocks. They say the gap between supply and demand is quickly narrowing, and could be back in balance by 2023. They also believe lithium production could be well above demand by at least 400,000…
Dow futures are up 800 points. NASDAQ futures are up 422 points. S&P 500 futures are up 112 points. All as inflation starts to show signs of easing. For October, consumer prices were up 0.4%, which was less than the…
Those New Year’s Resolution trades are on the move. On November 1, we noted: Look at Planet Fitness (PLNT) for example. For the last several years, the stock tends to take off around the holidays. It’s even starting to do…
Hurricane season is still wreaking havoc. After Hurricane Ian ran through Florida in late September, the state may have to contend with another one. Hopefully, it won’t be as severe. Right now, we know “Nicole” is a subtropical storm that…
We’ve seen substantial demand for inflation proof I-bonds. So much so, investors crashed the U.S. Treasury’s Treasury Direct site. All as investors rushed to buy Series I savings bonds, which had a yield of 9.62%. These bonds are a type…
Here we go again. COVID-19 infections have been rising again in Europe, including the UK, France, and Italy. There’s also fear of an uptick in cases in the U.S., too. "In the past, what's happened in Europe often has been…
Psychedelic stocks could see massive attention, near-term. Especially those associated with psilocybin. Here’s what we already know. Compass Pathways is preparing to launch Phase 3 human trials with psilocybin by the end of this year. They’ll enroll 1,000 participants. According…